Antin, C., Tauziède-Espariat, A., Debily, M., Castel, D., Grill, J., Pagès, M., . . . Varlet, P. (2020). EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression. Acta Neuropathol Commun.
Chicago Stili AlıntıAntin, C., et al. "EZHIP Is a Specific Diagnostic Biomarker for Posterior Fossa Ependymomas, Group PFA and Diffuse Midline Gliomas H3-WT With EZHIP Overexpression." Acta Neuropathol Commun 2020.
MLA AlıntıAntin, C., et al. "EZHIP Is a Specific Diagnostic Biomarker for Posterior Fossa Ependymomas, Group PFA and Diffuse Midline Gliomas H3-WT With EZHIP Overexpression." Acta Neuropathol Commun 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..